Parallax Volatility Advisers
ONCE

Parallax Volatility Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Parallax Volatility Advisers’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20,000
Closed -$1.21M – 4646
2015
Q2 		$1.21M Buy
+20,000
New +$1.32M ﹤0.01% 1273

Other funds holding ONCE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Parallax Volatility Advisers's ONCE Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2018, closing a stake of 23,171 shares — an estimated $1.34M sold.

Parallax Volatility Advisers first reported a position in ONCE in Q2 2015 and held it in 3 quarters. The position peaked at $1.19M in Q4 2017. 162 funds tracked by Wall St. Rank hold ONCE as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 23,171 Spark Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $1.34M.
  • Parallax Volatility Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • Parallax Volatility Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $1.19M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.